Breaking News, Collaborations & Alliances

BioLife Solutions Secures $2.7 Million Contract

Will provide cold chain management and storage of COVID-19 vaccines.

By: Contract Pharma

Contract Pharma Staff

BioLife Solutions Inc.’s SciSafe division has been awarded a two year contract from a large pharmaceutical company for cold chain management and storage of COVID-19 vaccines. The contract value is approximately $2.7 million.   Mike Rice, BioLife CEO, commented, “Garrie Richardson, former SciSafe CEO and now general manager, Biologic Storage Services at BioLife, has built a great business and it’s clear SciSafe’s scalable and high-quality operations are driving interest from lea...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters